Terminated PHASE2 INTERVENTIONAL 3-arm NCT01475929

Effect of Probiotic Supplement on Bowel Function (IBS2)

Sponsor: Danisco

Updated 5 times since 2017 Last updated: Aug 11, 2015 Started: Jun 30, 2011 Primary completion: May 31, 2012 Completion: May 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Protocol violations

Other terminated trials from Danisco

See all terminations from Danisco

Other Irritable Bowel Syndrome trials with similar outcome

Browse all Irritable Bowel Syndrome trials

A PHASE2 clinical study on Irritable Bowel Syndrome, this trial is terminated or withdrawn. The trial is conducted by Danisco and has accumulated 5 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE2

First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Danisco

Data source: Danisco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Helsinki, Finland